Concepedia

Mohammad Saki

MS

5

Publications

158

Citations

5

H-Index

2018

Active since

Affiliations

University of California, Los Angeles(Current)

UCLA Jonsson Comprehensive Cancer Center

Mohammad Saki is an author at University of California, Los Angeles specializing in medicine, radiation medicine, and radiation oncology.

Top concepts

Publications per year

2018–2021

5

Publications

5

The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma

Kruttika Bhat, Mohammad Saki, Erina Vlashi et al. · Proceedings of the National Academy of Sciences · 2020 · 70 citations · Full text

, , +19

Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of Glioblastoma

Kruttika Bhat, Mohammad Saki, Fei Cheng et al. · JNCI Journal of the National Cancer Institute · 2021 · 37 citations · Full text

Radiation mitigation of the intestinal acute radiation injury in mice by 1-[(4-nitrophenyl)sulfonyl]-4-phenylpiperazine

Sara Duhachek-Muggy, Kruttika Bhat, Paul Mark B. Medina et al. · Stem Cells Translational Medicine · 2019 · 20 citations · Full text

1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine treatment after brain irradiation preserves cognitive function in mice

Kruttika Bhat, Paul Mark B. Medina, Ling He et al. · Neuro-Oncology · 2020 · 19 citations · Full text

1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine increases the number of Peyer’s patch-associated regenerating crypts in the small intestines after radiation injury

Kruttika Bhat, Sara Duhachek-Muggy, Renuka Ramanathan et al. · Radiotherapy and Oncology · 2018 · 12 citations

, , +8

Rows per page

1–5 of 5